2013 Chancroid Diagnostics Market: US, Europe, Japan TestVolume, Sales Forecasts and Supplier Shares by CountryReport Deta...
E. Emerging Diagnostic Technologies1. Molecular Diagnostics2. Monoclonal Antibodies3. Immunoassays4. Differential Light Sc...
AffymetrixBeckman Coulter/DanaherBecton DickinsonbioMerieuxBio-RadCepheidDiamedixDiaSorinEiken ChemicalEnzo BiochemFujireb...
U.K.Chancroid Test Volume and Diagnostics Sales Forecast by Market SegmentU.S.A.Chancroid Test Volume and Diagnostics Sale...
Upcoming SlideShare
Loading in …5
×

2013 Chancroid Diagnostics Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country

236 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
236
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

2013 Chancroid Diagnostics Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country

  1. 1. 2013 Chancroid Diagnostics Market: US, Europe, Japan TestVolume, Sales Forecasts and Supplier Shares by CountryReport Details:Published:December 2012No. of Pages: 220Price: Single User License – US$3850This report presents a detailed analysis of the Chancroid diagnostics market in the US, Europe(France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chancroiddefinition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year testvolume and sales forecasts by country for the following market segments:•Hospitals•Commercial/Private Labs•Physician Offices•Public Health LabsIn addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Chancroid tests.Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies,Immunoassays, IT and other technologies; reviews features and operating characteristics ofautomated analyzers; profiles leading suppliers and recent market entrants developing innovativetechnologies and products; and identifies emerging business expansion opportunities, alternativemarket penetration strategies, market entry barriers and risks, and strategic planning issues andconcerns.Get your copy of this report @http://www.reportsnreports.com/reports/211274-2013-chancroid-diagnostics-market-us-europe-japan-test-volume-sales-forecasts-and-supplier-shares-by-country.htmlMajor points covered in Table of Contents of this report includeTable of ContentsI. IntroductionII. Chancroid Worldwide Market and Technology OverviewA. BackgroundB. Diagnostic TestsC. Vaccines and DrugsD. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher,BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
  2. 2. E. Emerging Diagnostic Technologies1. Molecular Diagnostics2. Monoclonal Antibodies3. Immunoassays4. Differential Light Scattering5. Information Technology6. Artificial Intelligence7. Liposomes8. Flow Cytometry9. Chromatography10. Diagnostic Imaging11. Gel Microdroplets12. OtherIII. France: Test Volume and Diagnostics Sales Forecast by Market SegmentIV. Germany: Test Volume and Diagnostics Sales Forecast by Market SegmentV. Italy: Test Volume and Diagnostics Sales Forecast by Market SegmentVI. Japan: Test Volume and Diagnostics Sales Forecast by Market SegmentVII. Spain: Test Volume and Diagnostics Sales Forecast by Market SegmentVIII. UK: Test Volume and Diagnostics Sales Forecast by Market SegmentIX. USA: Market Size, Growth and Major Suppliers’ Sales and Market SharesX. Alternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for Decentralized Testing Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market SegmentationXI. Potential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesXII. Competitive AssessmentsAbbott
  3. 3. AffymetrixBeckman Coulter/DanaherBecton DickinsonbioMerieuxBio-RadCepheidDiamedixDiaSorinEiken ChemicalEnzo BiochemFujirebioGen-ProbeHologicID BiomedicalInnogenetics/SolvayKreatechLife TechnologyLonzaNanogen/ElitechNovartis DiagnosticsOrtho-Clinical DiagnosticsQiagenRocheScienionSequenomSeraCareSiemensTakara BioThermo FisherWallacWakoList of TablesFranceChancroid Test Volume and Diagnostics Sales Forecast by Market SegmentGermanyChancroid Test Volume and Diagnostics Sales Forecast by Market SegmentItalyChancroid Test Volume and Diagnostics Sales Forecast by Market SegmentJapanChancroid Test Volume and Diagnostics Sales Forecast by Market SegmentSpainChancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  4. 4. U.K.Chancroid Test Volume and Diagnostics Sales Forecast by Market SegmentU.S.A.Chancroid Test Volume and Diagnostics Sales Forecast by Market SegmentU.S.A.Chancroid Diagnostics Sales by Major SupplierContact: sales@reportsandreports.com for more information.

×